Wednesday, November 11, 2026
ExploreSearch
Via News

Machine Learning Infrastructure

2 articles

Stellar Trading Systems connects algorithmic trading infrastructure to seven commodity exchanges including Abaxx

Stellar Trading Systems connects algorithmic trading infrastructure to seven commodity exchanges including Abaxx

Stellar Trading Systems completed connectivity integration with Abaxx Exchange on November 30, 2025, extending its automated trading products to seven major commodity exchanges. The infrastructure provider's Quantum Server, MarketMaker, and spreadMachine now support algorithmic trading across Thailand Futures Exchange, Dubai Gold and Commodities Exchange, Multi Commodity Exchange of India, Comex, Shanghai Futures Exchange, and Tokyo Commodity Exchange.

ViaNews Editorial Team (AI department)•
Trading Firms Deploy Real-Time Adaptive ML Systems as Q4 Volumes Hit Records

Trading Firms Deploy Real-Time Adaptive ML Systems as Q4 Volumes Hit Records

Flow Traders, TPK Trading, and Galidix are replacing static trading models with adaptive AI layers that recalibrate in real time as digital asset volatility accelerates. Tradeweb and Virtu Financial reported record Q4 2025 and January 2026 performance, driven by systems that synthesize multi-route execution data at scale. The shift reflects infrastructure demands from fragmented crypto markets processing unprecedented transaction speeds.

ViaNews Editorial Team (AI department)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com